InsidersTradesSigma
Discover the detailed record of transactions filed by Goldberg Itzhak, Autre. Director active across 1 companies, notably Angion Biomedica Corp.. Aggregated, 6 disclosures have been recorded. Total volume traded: €434k. The latest transaction was filed on 6 December 2021 — Cession. Regulator: SEC (Form 4). The full history is openly available.
6 of 6 declarations
Itzhak Goldberg is associated with Angion Biomedica Corp. Although his role is not specified, he contributes to the company's mission in the biopharmaceutical field. His expertise is valuable for developing innovative therapeutic solutions. He plays a role in the strategy and governance of the company.